Stock Comparison
HLN vs TAK
Haleon plc and Takeda Pharmaceutical Co Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$43.55B
$55.20B
P/E (TTM)
20.2
—
Forward P/E
18.0
10.6
Price/Sales
3.9
0.0
Price/Book
2.0
1.2
EV/EBITDA
14.0
22.6
Dividend Yield
1.93%
1.85%
Profitability
Net Margin
14.43%
4.25%
Operating Margin
21.32%
10.89%
Return on Equity
10.10%
-2.26%
Return on Assets
5.08%
2.69%
Growth (YoY)
Revenue Growth
2.20%
10.20%
Earnings Growth
-4.50%
-9.80%
Price & Risk
Beta
0.2
0.1
52-Week High
$11.12
$18.80
52-Week Low
$8.61
$13.23
Analyst Target
$11.99
$21.59
Compare HLN and TAK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.